CDC37 and prostate carcinoma: The overexpressed MZF1 occupied genomic CDC37 promoter regions (−0.4k and −1.8k regions that contain MZF1-binding sites), further indicating that the CDC37 gene is regulated by MZF1 binding to these MZF1 binding sites in prostate cancer, as suggested by chromatin immunoprecipitation (ChIP) assay (Figure 2E).